Gilead reduces price of AmBisome (liposomal amphotericin B) for cryptococcal meningitis in HIV/AIDS
September 28, 2018
Gilead Sciences, a pharmaceutical company with an interest in AIDS, hepatitis C and infectious diseases, have expanded their access initiative for AmBisome (a liposomal preparation of amphotericin B) to include cryptococcal meningitis, where previously it was only for leishmaniasis. Governments and public sector procurers in 116 low- and middle-income countries can now buy the drug…
Article published in Le Monde highlights threats from fungal infections of humans, crops and wildlife
September 20, 2018
PARIS – An article published in Le Monde brings to public attention the deadly threat that fungal infections pose to human health, food security and wildlife. It presents burden of disease statistics compiled by GAFFI and includes a quote from Professor David Denning, highlighting their key role in this area. The article emphasises the crucial…
Histoplasmosis competes with TB as top killer of Latin American AIDS patients
August 30, 2018
Both acquired through the lungs, TB from other people, histoplasmosis from disturbed soil are both potentially fatal in advanced HIV disease. Now Antoine Adenis and colleagues from INSERM and Centre Hospitalier de Cayenne, Cayenne have modeled the annual incidence of both infections throughout central and South America. For 2012, 6710 to 15 657 cases of…
Is it TB or a fungal lung infection? New life saving guidelines released today
August 7, 2018
Currently 45% of TB diagnosis is only clinical and not confirmed with tests. Up to 20% of these diagnoses are incorrect. A common missed diagnosis is fungal lung infection. The most common of these is chronic pulmonary aspergillosis or CPA. The treatment of TB and CPA treatment is completely different and untreated CPA has an…
New figures show 138 million women suffer from recurrent thrush
August 2, 2018
Around 138 million women are affected by a distressing but treatable fungal infection world-wide, according to a research review by University of Manchester scientists. And the incidence of recurrent thrush, warns lead researcher Dr Riina Rautemaa-Richardson, is set to rise to an estimated 158 million people by 2030. The team from The University of Manchester…